ReviewJournal of inflammation research2021

Targeting Neuroinflammation via Purinergic P2 Receptors for Disease Modification in Drug-Refractory Epilepsy.

Tobias Engel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.